Safety and efficacy of percutaneous transluminal pulmonary angioplasty in elderly patients

Ryoji Yanagisawa, Masaharu Kataoka, Takumi Inami, Nobuhiko Shimura, Haruhisa Ishiguro, Keiichi Fukuda, Hideaki Yoshino, Toru Satoh

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background Percutaneous transluminal pulmonary angioplasty (PTPA) is a recently developed catheter-based therapy for chronic thromboembolic pulmonary hypertension (CTEPH). The aim of the present study was to investigate the safety and efficacy of PTPA in elderly patients with CTEPH. Methods In all, 257 PTPA sessions in 70 patients (median age 63 years) were analyzed. Patients were divided into two groups according to age: (i) a younger group (< 65 years; n = 39); and (ii) an elderly group (≥ 65 years; n = 31). Results Hemodynamic improvements were comparable between the younger and elderly groups (63.1% vs. 68.2% decrease in pulmonary vascular resistance, respectively; P > 0.05). The median length of stay in the intensive care unit after each session (1.0 vs. 1.0 days) and in hospital per session (9.2 vs. 9.4 days) was similar between the two groups (P > 0.05 for all). The prevalence of reperfusion pulmonary edema (23.4% vs. 26.3% across all sessions) and other complications, such as contrast dye-induced nephropathy (0% vs. 2.0%), infection (0% vs. 0%), and neurological complications (0% vs. 1.0%), was comparable in the younger vs. elderly groups (P > 0.05 for all). One-year all-cause mortality was similar in the younger and elderly groups (0% vs. 3.2%, respectively; P > 0.05). Conclusions PTPA can be performed safely and effectively, even in elderly patients, and could be considered as an alternative therapeutic strategy for elderly patients who are too fragile for pulmonary endarterectomy (PEA) or who are treated in institutions without highly experienced PEA surgeons.

Original languageEnglish
Pages (from-to)285-289
Number of pages5
JournalInternational Journal of Cardiology
Volume175
Issue number2
DOIs
Publication statusPublished - 2014 Aug 1

Fingerprint

Angioplasty
Safety
Lung
Endarterectomy
Pulmonary Hypertension
Pulmonary Edema
Reperfusion
Intensive Care Units
Length of Stay
Coloring Agents
Catheters
Mortality
Therapeutics
Infection

Keywords

  • Age
  • Chronic thromboembolic pulmonary hypertension
  • Elderly patients
  • Percutaneous transluminal pulmonary angioplasty
  • Pulmonary endarterectomy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Safety and efficacy of percutaneous transluminal pulmonary angioplasty in elderly patients. / Yanagisawa, Ryoji; Kataoka, Masaharu; Inami, Takumi; Shimura, Nobuhiko; Ishiguro, Haruhisa; Fukuda, Keiichi; Yoshino, Hideaki; Satoh, Toru.

In: International Journal of Cardiology, Vol. 175, No. 2, 01.08.2014, p. 285-289.

Research output: Contribution to journalArticle

Yanagisawa, R, Kataoka, M, Inami, T, Shimura, N, Ishiguro, H, Fukuda, K, Yoshino, H & Satoh, T 2014, 'Safety and efficacy of percutaneous transluminal pulmonary angioplasty in elderly patients', International Journal of Cardiology, vol. 175, no. 2, pp. 285-289. https://doi.org/10.1016/j.ijcard.2014.05.011
Yanagisawa, Ryoji ; Kataoka, Masaharu ; Inami, Takumi ; Shimura, Nobuhiko ; Ishiguro, Haruhisa ; Fukuda, Keiichi ; Yoshino, Hideaki ; Satoh, Toru. / Safety and efficacy of percutaneous transluminal pulmonary angioplasty in elderly patients. In: International Journal of Cardiology. 2014 ; Vol. 175, No. 2. pp. 285-289.
@article{f238dd46ed6c4bbf8ef222cbe9b6ab01,
title = "Safety and efficacy of percutaneous transluminal pulmonary angioplasty in elderly patients",
abstract = "Background Percutaneous transluminal pulmonary angioplasty (PTPA) is a recently developed catheter-based therapy for chronic thromboembolic pulmonary hypertension (CTEPH). The aim of the present study was to investigate the safety and efficacy of PTPA in elderly patients with CTEPH. Methods In all, 257 PTPA sessions in 70 patients (median age 63 years) were analyzed. Patients were divided into two groups according to age: (i) a younger group (< 65 years; n = 39); and (ii) an elderly group (≥ 65 years; n = 31). Results Hemodynamic improvements were comparable between the younger and elderly groups (63.1{\%} vs. 68.2{\%} decrease in pulmonary vascular resistance, respectively; P > 0.05). The median length of stay in the intensive care unit after each session (1.0 vs. 1.0 days) and in hospital per session (9.2 vs. 9.4 days) was similar between the two groups (P > 0.05 for all). The prevalence of reperfusion pulmonary edema (23.4{\%} vs. 26.3{\%} across all sessions) and other complications, such as contrast dye-induced nephropathy (0{\%} vs. 2.0{\%}), infection (0{\%} vs. 0{\%}), and neurological complications (0{\%} vs. 1.0{\%}), was comparable in the younger vs. elderly groups (P > 0.05 for all). One-year all-cause mortality was similar in the younger and elderly groups (0{\%} vs. 3.2{\%}, respectively; P > 0.05). Conclusions PTPA can be performed safely and effectively, even in elderly patients, and could be considered as an alternative therapeutic strategy for elderly patients who are too fragile for pulmonary endarterectomy (PEA) or who are treated in institutions without highly experienced PEA surgeons.",
keywords = "Age, Chronic thromboembolic pulmonary hypertension, Elderly patients, Percutaneous transluminal pulmonary angioplasty, Pulmonary endarterectomy",
author = "Ryoji Yanagisawa and Masaharu Kataoka and Takumi Inami and Nobuhiko Shimura and Haruhisa Ishiguro and Keiichi Fukuda and Hideaki Yoshino and Toru Satoh",
year = "2014",
month = "8",
day = "1",
doi = "10.1016/j.ijcard.2014.05.011",
language = "English",
volume = "175",
pages = "285--289",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Safety and efficacy of percutaneous transluminal pulmonary angioplasty in elderly patients

AU - Yanagisawa, Ryoji

AU - Kataoka, Masaharu

AU - Inami, Takumi

AU - Shimura, Nobuhiko

AU - Ishiguro, Haruhisa

AU - Fukuda, Keiichi

AU - Yoshino, Hideaki

AU - Satoh, Toru

PY - 2014/8/1

Y1 - 2014/8/1

N2 - Background Percutaneous transluminal pulmonary angioplasty (PTPA) is a recently developed catheter-based therapy for chronic thromboembolic pulmonary hypertension (CTEPH). The aim of the present study was to investigate the safety and efficacy of PTPA in elderly patients with CTEPH. Methods In all, 257 PTPA sessions in 70 patients (median age 63 years) were analyzed. Patients were divided into two groups according to age: (i) a younger group (< 65 years; n = 39); and (ii) an elderly group (≥ 65 years; n = 31). Results Hemodynamic improvements were comparable between the younger and elderly groups (63.1% vs. 68.2% decrease in pulmonary vascular resistance, respectively; P > 0.05). The median length of stay in the intensive care unit after each session (1.0 vs. 1.0 days) and in hospital per session (9.2 vs. 9.4 days) was similar between the two groups (P > 0.05 for all). The prevalence of reperfusion pulmonary edema (23.4% vs. 26.3% across all sessions) and other complications, such as contrast dye-induced nephropathy (0% vs. 2.0%), infection (0% vs. 0%), and neurological complications (0% vs. 1.0%), was comparable in the younger vs. elderly groups (P > 0.05 for all). One-year all-cause mortality was similar in the younger and elderly groups (0% vs. 3.2%, respectively; P > 0.05). Conclusions PTPA can be performed safely and effectively, even in elderly patients, and could be considered as an alternative therapeutic strategy for elderly patients who are too fragile for pulmonary endarterectomy (PEA) or who are treated in institutions without highly experienced PEA surgeons.

AB - Background Percutaneous transluminal pulmonary angioplasty (PTPA) is a recently developed catheter-based therapy for chronic thromboembolic pulmonary hypertension (CTEPH). The aim of the present study was to investigate the safety and efficacy of PTPA in elderly patients with CTEPH. Methods In all, 257 PTPA sessions in 70 patients (median age 63 years) were analyzed. Patients were divided into two groups according to age: (i) a younger group (< 65 years; n = 39); and (ii) an elderly group (≥ 65 years; n = 31). Results Hemodynamic improvements were comparable between the younger and elderly groups (63.1% vs. 68.2% decrease in pulmonary vascular resistance, respectively; P > 0.05). The median length of stay in the intensive care unit after each session (1.0 vs. 1.0 days) and in hospital per session (9.2 vs. 9.4 days) was similar between the two groups (P > 0.05 for all). The prevalence of reperfusion pulmonary edema (23.4% vs. 26.3% across all sessions) and other complications, such as contrast dye-induced nephropathy (0% vs. 2.0%), infection (0% vs. 0%), and neurological complications (0% vs. 1.0%), was comparable in the younger vs. elderly groups (P > 0.05 for all). One-year all-cause mortality was similar in the younger and elderly groups (0% vs. 3.2%, respectively; P > 0.05). Conclusions PTPA can be performed safely and effectively, even in elderly patients, and could be considered as an alternative therapeutic strategy for elderly patients who are too fragile for pulmonary endarterectomy (PEA) or who are treated in institutions without highly experienced PEA surgeons.

KW - Age

KW - Chronic thromboembolic pulmonary hypertension

KW - Elderly patients

KW - Percutaneous transluminal pulmonary angioplasty

KW - Pulmonary endarterectomy

UR - http://www.scopus.com/inward/record.url?scp=84904258042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904258042&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2014.05.011

DO - 10.1016/j.ijcard.2014.05.011

M3 - Article

VL - 175

SP - 285

EP - 289

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 2

ER -